Aleksandra Klisić1, Nebojša Kavarić2, Vesna Spasojević-Kalimanovska3, Jelena Kotur-Stevuljević3, Ana Ninić3. 1. University of Montenegro, Faculty of Medicine, Primary Health Care Center, Center for Laboratory Diagnostics, Podgorica, Montenegro. 2. University of Montenegro, Faculty of Medicine, Primary Health Care Center, Podgorica, Montenegro. 3. University of Belgrade, Faculty of Pharmacy, Department for Medical Biochemistry, Belgrade.
Abstract
BACKGROUND: Association between endocan and nontraditional anthropometric indices, as distinct cardiovascular disease risk factors, has not been examined in previous studies. Endocan is a novel inflammation biomarker with its higher levels involved in cardiometabolic diseases development. Taking into consideration that obesity is an independent risk factor for many cardiometabolic diseases, we aimed to explore the relationship between endocan levels and novel anthropometric indices [i.e., body adiposity index (BAI), cardiometabolic index (CMI), a body shape index, body roundness index, conicity index, lipid accumulation product index and visceral adiposity index] and traditional ones [i.e., waist circumference, hip circumference, body mass index, waist-to-height ratio and waist-to-hip ratio] in adult population. METHODS: A total of 177 participants were included. Anthropometric indices and biochemical parametres were measured. RESULTS: Univariate regression analysis demonstrated positive correlations of endocan and almost all anthropometric data. To explore independent associations of endocan and anthropometric parameters, the Model which fulfilled criteria for ordinal regression testing was created. Adjusted odds for BAI given in the Model (OR=1.120, 95% CI 1.036-1.212, P=0.004), demonstrated that a rise in BAI by 1 unit increased the probability of higher endocan concentration by 12%. As well, a rise in CMI for 1 unit, increased the probability for higher endocan levels for 2.6 times (OR=2.599, 95% CI 1.006-6.712, P=0.049). A total of 20.1% of variation in endocan levels could be explained by this Model. CONCLUSIONS: Non-traditional obesity indices, BAI and CMI independently correlated with higher serum endocan levels in adult population. 2021 Aleksandra Klisić, Nebojša Kavarić, Vesna Spasojević-Kalimanovska, Jelena Kotur-Stevuljević, Ana Ninić, published by CEON/CEES.
BACKGROUND: Association between endocan and nontraditional anthropometric indices, as distinct cardiovascular disease risk factors, has not been examined in previous studies. Endocan is a novel inflammation biomarker with its higher levels involved in cardiometabolic diseases development. Taking into consideration that obesity is an independent risk factor for many cardiometabolic diseases, we aimed to explore the relationship between endocan levels and novel anthropometric indices [i.e., body adiposity index (BAI), cardiometabolic index (CMI), a body shape index, body roundness index, conicity index, lipid accumulation product index and visceral adiposity index] and traditional ones [i.e., waist circumference, hip circumference, body mass index, waist-to-height ratio and waist-to-hip ratio] in adult population. METHODS: A total of 177 participants were included. Anthropometric indices and biochemical parametres were measured. RESULTS: Univariate regression analysis demonstrated positive correlations of endocan and almost all anthropometric data. To explore independent associations of endocan and anthropometric parameters, the Model which fulfilled criteria for ordinal regression testing was created. Adjusted odds for BAI given in the Model (OR=1.120, 95% CI 1.036-1.212, P=0.004), demonstrated that a rise in BAI by 1 unit increased the probability of higher endocan concentration by 12%. As well, a rise in CMI for 1 unit, increased the probability for higher endocan levels for 2.6 times (OR=2.599, 95% CI 1.006-6.712, P=0.049). A total of 20.1% of variation in endocan levels could be explained by this Model. CONCLUSIONS: Non-traditional obesity indices, BAI and CMI independently correlated with higher serum endocan levels in adult population. 2021 Aleksandra Klisić, Nebojša Kavarić, Vesna Spasojević-Kalimanovska, Jelena Kotur-Stevuljević, Ana Ninić, published by CEON/CEES.
Authors: Rogério Tosta de Almeida; Alexandre da Costa Pereira; Maria de Jesus Mendes da Fonseca; Sheila Maria Alvim de Matos; Estela Motta Leão Aquino Journal: Clin Nutr Date: 2019-06-13 Impact factor: 7.324
Authors: M Wellner; F Herse; J Janke; K Gorzelniak; S Engeli; D Bechart; P Lasalle; F C Luft; A M Sharma Journal: Horm Metab Res Date: 2003-04 Impact factor: 2.936
Authors: J Janke; S Engeli; K Gorzelniak; M Feldpausch; U Heintze; J Böhnke; M Wellner; F Herse; P Lassalle; F C Luft; A M Sharma Journal: Horm Metab Res Date: 2006-01 Impact factor: 2.936
Authors: Aleksandra Klisić; Nebojša Kavarić; Ludovico Abenavoli; Verica Stanišić; Vesna Spasojević-Kalimanovska; Jelena Kotur-Stevuljević; Ana Ninić Journal: J Med Biochem Date: 2020-09-02 Impact factor: 3.402
Authors: Protasio Lemos da Luz; Desiderio Favarato; Jose Rocha Faria-Neto; Pedro Lemos; Antonio Carlos Palandri Chagas Journal: Clinics (Sao Paulo) Date: 2008-08 Impact factor: 2.365